Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2019 R33 RFA-CA-18-003 TAVANA, HOSSEIN UNIVERSITY OF AKRON A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery Active
2002 R33 PAR-01-104 BEACHY, PHILIP A JOHNS HOPKINS UNIVERSITY GENOME-BASED TARGETING OF THE HEDGEHOG PATHWAY IN CANCER Complete
2018 R33 RFA-CA-17-011 SCHRUM, ADAM G UNIVERSITY OF MISSOURI-COLUMBIA Multiplex matrix ELISA for T cell protein-interaction networks in cancer Active
2007 R33 RFA-CA-07-016 MACBEATH, GAVIN HARVARD UNIVERSITY QUANTITATIVE INTERACTION NETWORKS FOR TYROSINE-PHOSPHORYLATED PROTEINS Complete
2014 R33 RFA-CA-13-002 LOEB, LAWRENCE A UNIVERSITY OF WASHINGTON VALIDATION AND ADVANCED DEVELOPMENT OF DUPLEX SEQUENCING Complete
2017 R33 RFA-CA-16-002 SINGH, ANKUR CORNELL UNIVERSITY LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics NCE
2001 R33 PAR-98-067 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER Complete
2013 R33 RFA-CA-12-003 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER ADVANCED DEVELOPMENT OF IMMUNO-MRM TECHNOLOGY TO ANALYZE ARCHIVED CANCER TISSUES Complete
2013 R33 RFA-CA-12-003 TACKETT, ALAN JACKSON UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION Complete
2016 R33 RFA-CA-15-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS GESI: a novel technology for functional imaging in living cells Complete
2012 R33 RFA-CA-12-003 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE ACTIVATABLE ONE-DROP AND ONE-STEP ASSAY FOR CIRCULATING TUMOR CE Complete
2019 R33 RFA-CA-18-003 SCHNECK, JONATHAN P JOHNS HOPKINS UNIVERSITY A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells Active
2002 R33 PAR-01-104 WAGGONER, ALAN S CARNEGIE-MELLON UNIVERSITY NEAR IR FLUORESCENT PROBES/MOLECULAR ANALYSIS OF CANCER Complete
2018 R33 RFA-CA-17-011 TEWARI, MUNEESH (contact); WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations Active
2014 R33 RFA-CA-13-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA MULTIPLEXED KINASE BIOSENSOR TECHNOLOGY TO DETECT LEUKEMIA SIGNALING WITH MASS SP Complete
2017 R33 RFA-CA-16-002 YATES, JOHN R SCRIPPS RESEARCH INSTITUTE Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry NCE
2001 R33 PAR-98-067 WIND, ROBERT A BATTELLE PACIFIC NORTHWEST LABORATORIES INTEGRATED OPTICAL/MAGNETIC RESONANCE MICROSCOPY Complete
2013 R33 RFA-CA-12-003 CUNNINGHAM, BRIAN T. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN PHOTONIC CRYSTAL ENHANCED FLUORESCENCE: DEVELOPMENT OF SENSORS STRUCTURES AND DET Complete
2016 R33 RFA-CA-15-003 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY Protein painting identifies therapeutic targets at protein-protein interfaces NCE
2012 R33 RFA-CA-12-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS DISCOVERY OF DEATH LIGANDS AGAINST CANCERS Complete
2019 R33 RFA-CA-18-003 SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation Active
2002 R33 PAR-01-104 SPEICHER, DAVID W. WISTAR INSTITUTE DEVELOPMENT OF METHODS FOR CANCER BIOMARKER DETECTION Complete
2010 R33 RFA-CA-09-005 WANG, SHAN X. STANFORD UNIVERSITY CANCER SAMPLE PREPARATION WITH MICROMACHINED MAGNETIC SIFTER AND NANOPARTICLES Complete
2014 R33 RFA-CA-13-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER ADVANCED METHODS TO EVALUATE EXTRACELLULAR MATRIX AND CROSSLINKING IN THE TUMOR M Complete
2017 R33 RFA-CA-16-002 LU, CHANG VIRGINIA POLYTECHNIC INST AND ST UNIV Next-generation MOWChIP-seq for high-throughput epigenomic profiling using clinically relevant samples Complete
2001 R33 PAR-98-067 WANG, YUE CATHOLIC UNIVERSITY OF AMERICA INTELLIGENT MAPPING OF GENE EXPRESSION PROFILES Complete
2013 R33 RFA-CA-12-005 TSENG, HSIAN-RONG UNIVERSITY OF CALIFORNIA LOS ANGELES MOLECULAR AND FUNCTIONAL ANALYSIS OF SINGLE CIRCULATING MELANOMA CELLS Complete
2016 R33 RFA-CA-15-003 WEISS, GREGORY A. UNIVERSITY OF CALIFORNIA-IRVINE Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors NCE
2012 R33 RFA-CA-12-003 NOLLING, JORK N PRIMERADX, INC. A HIGHLY MULTIPLEXED PCR PLATFORM FOR GENE EXPRESSION PROFILING FROM FFPE TISSUE Complete
2019 R33 RFA-CA-18-003 FIOLKA, RETO PAUL UT SOUTHWESTERN MEDICAL CENTER Multiscale microscope for 3D cancer imaging in model organisms and organoids Active
2002 R33 PAR-01-106 SHAUGHNESSY, JOHN DAMIAN UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK MOLECULAR DIAGNOSIS AND PROGNOSIS OF MULTIPLE MYELOMA Complete
2015 R33 RFA-CA-14-004 BURKE, PETER J. UNIVERSITY OF CALIFORNIA-IRVINE HIGH-THROUGHPUT ON-CHIP PLATFORM FOR INTERROGATION OF MITOCHONDRIAL MEMBRANE POTENTIAL AND APOPTOSIS Complete
2010 R33 RFA-CA-09-007 BESTOR, TIMOTHY H COLUMBIA UNIVERSITY HEALTH SCIENCES MAMMARY CARCINOMA AND GENOMIC METHYLATION PATTERNS Complete
2014 R33 RFA-CA-13-004 NOLAN, GARRY P. STANFORD UNIVERSITY HIGHLY MULTIPLEXED ION-BEAM TISSUE MOLECULAR IMAGING WITH SUB-MICRON RESOLUTION Complete
2017 R33 RFA-CA-16-002 ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer NCE
2001 R33 PAR-99-100 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS PEPTIDE MICROARRAY FOR CANCER CELL SURFACE RECEPTORS Complete
2007 R21 RFA-CA-07-002 COOPER, LAURENCE J.N. UT MD ANDERSON CANCER CTR UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY Complete
2006 R21 RFA-CA-06-004 O'LEARY, TIMOTHY J. AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF RNA FROM FORMALIN-FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 WIRTZ, DENIS JOHNS HOPKINS UNIVERSITY HIGH-THROUGHPUT INTRACELLULAR MICRORHEOLOGY: A NEW TOOL FOR CANCER RESEARCH Complete
2016 R21 RFA-CA-15-002 MATOUSCHEK, ANDREAS UNIVERSITY OF TEXAS, AUSTIN DEVELOPMENT OF PROTEASOME ADAPTORS TO CATALYTICALLY DEPLETE SPECIFIC PROTEINS FROM CELLS Complete
2000 R21 PAR-99-100 FORTINA, PAOLO M CHILDREN'S HOSPITAL OF PHILADELPHIA FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER Complete
2008 R21 RFA-CA-07-037 YANNELLI, JOHN R. UNIVERSITY OF KENTUCKY CRYOPREPARATION OF PBMC FOR IMMUNOTHERAPY AND IMMUNE ASSESSMENT STUDIES. Complete
2011 R21 RFA-CA-10-005 RAO, JIANGHONG STANFORD UNIVERSITY NANOTECHNOLOGY FOR MULTIPLEX DETECTION OF ENZYMES Complete
2018 R21 RFA-CA-17-012 SKARDAL, ALEKSANDER (contact); STROWD, ROY ERVIN WAKE FOREST UNIVERSITY HEALTH SCIENCES Predicting Tumor Heterogeneity Evolution After Therapy In Patient-Derived Ex Vivo Glioblastoma Organoids Active
1999 R21 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
1999 R21 PAR-98-067 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES ULTRA-SENSITIVE APPROACH FOR MONITORING GENE PRODUCTION Complete
2007 R21 RFA-CA-07-002 KERR, WILLIAM GARROW H. LEE MOFFITT CANCER CTR & RES INST DEFINING THE MULTIPLE MYELOMA KINOME Complete
2017 R21 RFA-CA-16-001 WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Single-molecule counting of cancer biomarker miRNAs in human biofluids Complete
2006 R21 RFA-CA-06-004 JU, JINGFANG UNIVERSITY OF SOUTH ALABAMA NOVEL METHOD FOR ISOLATING ACTIVELY TRANSLATED MRNAS Complete
2009 R21 RFA-CA-08-006 KANDEL, EUGENE S ROSWELL PARK CANCER INSTITUTE CORP ARRAY-ASSISTED INSERTIONAL MUTAGENESIS FOR MOLECULAR ANALYSIS OF CANCER Complete

Pages